142 related articles for article (PubMed ID: 34880850)
21. [The Epidemiology of Carbapenemases in Escherichia coli and Klebsiella pneumoniae Isolated in 2019 in Turkey].
Süzük Yıldız S; Şimşek H; Bakkaloğlu Z; Numanoğlu Çevik Y; Hekimoğlu CH; Kılıç S; Alp Meşe E;
Mikrobiyol Bul; 2021 Jan; 55(1):1-16. PubMed ID: 33590977
[TBL] [Abstract][Full Text] [Related]
22. Gastrointestinal Carriage of Vancomycin-Resistant Enterococci and Carbapenem-Resistant Gram-Negative Bacteria in an Endemic Setting: Prevalence, Risk Factors, and Outcomes.
Vasilakopoulou A; Karakosta P; Vourli S; Tarpatzi A; Varda P; Kostoula M; Antoniadou A; Pournaras S
Front Public Health; 2020; 8():55. PubMed ID: 32257988
[No Abstract] [Full Text] [Related]
23. Do specific antimicrobial stewardship interventions have an impact on carbapenem resistance in Gram-negative bacilli? A multicentre quasi-experimental ecological study: time-trend analysis and characterization of carbapenemases.
Álvarez-Marín R; López-Cerero L; Guerrero-Sánchez F; Palop-Borras B; Rojo-Martín MD; Ruiz-Sancho A; Herrero-Rodríguez C; García MV; Lazo-Torres AM; López I; Martín-Hita L; Nuño-Álvarez E; Sánchez-Yebra W; Galán-Sánchez F; Reguera-Iglesias JM; Lepe JA; Peñalva G; Pascual Á; Cisneros JM;
J Antimicrob Chemother; 2021 Jun; 76(7):1928-1936. PubMed ID: 33769481
[TBL] [Abstract][Full Text] [Related]
24. Carbapenem resistant Pseudomonas aeruginosa and Acinetobacter baumannii at Mulago Hospital in Kampala, Uganda (2007-2009).
Kateete DP; Nakanjako R; Namugenyi J; Erume J; Joloba ML; Najjuka CF
Springerplus; 2016; 5(1):1308. PubMed ID: 27547682
[TBL] [Abstract][Full Text] [Related]
25. Genomically Informed Surveillance for Carbapenem-Resistant Enterobacteriaceae in a Health Care System.
Pecora ND; Li N; Allard M; Li C; Albano E; Delaney M; Dubois A; Onderdonk AB; Bry L
mBio; 2015 Jul; 6(4):e01030. PubMed ID: 26220969
[TBL] [Abstract][Full Text] [Related]
26. Estimating the effect of practicing nursing professionals density on cumulative carbapenem-resistance prevalence in gram-negative invasive Isolates: a 30 European country observational modeling study.
Kaba HEJ; Scheithauer S
Antimicrob Resist Infect Control; 2022 Feb; 11(1):41. PubMed ID: 35193670
[TBL] [Abstract][Full Text] [Related]
27. Characterization of Carbapenem-Resistant Escherichia coli Isolates Through the Whole-Genome Sequencing Analysis.
Luo Y; Luo R; Ding H; Ren X; Luo H; Zhang Y; Ye L; Cui S
Microb Drug Resist; 2018 Mar; 24(2):175-180. PubMed ID: 28686503
[TBL] [Abstract][Full Text] [Related]
28. Whole genome sequencing characterization of Slovenian carbapenem-resistant Klebsiella pneumoniae, including OXA-48 and NDM-1 producing outbreak isolates.
Benulič K; Pirš M; Couto N; Chlebowicz M; Rossen JWA; Zorec TM; Seme K; Poljak M; Lejko Zupanc T; Ružić-Sabljić E; Cerar T
PLoS One; 2020; 15(4):e0231503. PubMed ID: 32282829
[TBL] [Abstract][Full Text] [Related]
29. Cluster-distinguishing genotypic and phenotypic diversity of carbapenem-resistant Gram-negative bacteria in solid-organ transplantation patients: a comparative study.
Karampatakis T; Geladari A; Politi L; Antachopoulos C; Iosifidis E; Tsiatsiou O; Karyoti A; Papanikolaou V; Tsakris A; Roilides E
J Med Microbiol; 2017 Aug; 66(8):1158-1169. PubMed ID: 28758635
[No Abstract] [Full Text] [Related]
30. Genetic Diversity of Multidrug-Resistant
Rada AM; De La Cadena E; Agudelo CA; Pallares C; Restrepo E; Correa A; Villegas MV; Capataz C
Front Microbiol; 2021; 12():663020. PubMed ID: 34512563
[No Abstract] [Full Text] [Related]
31. Antibiotic consumption versus the prevalence of carbapenem-resistant Gram-negative bacteria at a tertiary hospital in China from 2011 to 2017.
Zhang D; Hu S; Sun J; Zhang L; Dong H; Feng W; Lei J; Dong Y
J Infect Public Health; 2019; 12(2):195-199. PubMed ID: 30385238
[TBL] [Abstract][Full Text] [Related]
32. In vitro activity of cefiderocol, a siderophore cephalosporin, against a recent collection of clinically relevant carbapenem-non-susceptible Gram-negative bacilli, including serine carbapenemase- and metallo-β-lactamase-producing isolates (SIDERO-WT-2014 Study).
Kazmierczak KM; Tsuji M; Wise MG; Hackel M; Yamano Y; Echols R; Sahm DF
Int J Antimicrob Agents; 2019 Feb; 53(2):177-184. PubMed ID: 30395986
[TBL] [Abstract][Full Text] [Related]
33. Characterization of carbapenem-resistant and XDR Pseudomonas aeruginosa in Canada: results of the CANWARD 2007-16 study.
McCracken MG; Adam HJ; Blondeau JM; Walkty AJ; Karlowsky JA; Hoban DJ; Zhanel GG; Mulvey MR;
J Antimicrob Chemother; 2019 Aug; 74(Suppl 4):iv32-iv38. PubMed ID: 31505643
[TBL] [Abstract][Full Text] [Related]
34. Carbapenem-resistant
Higashino HR; Marchi AP; Ruedas Martins RC; Bubach Carvalho L; Vieira Perdigão Neto L; Farrel Côrtes M; Nivaldo de Oliveira F; Tarsia Duarte EL; Guimaraes T; Rossi F; Ferreira AM; Rocha V; Costa SF
J Med Microbiol; 2021 Oct; 70(10):. PubMed ID: 34665114
[TBL] [Abstract][Full Text] [Related]
35. Heterogeneity of Carbapenem Resistance Mechanisms Among Gram-Negative Pathogens in Lebanon: Results of the First Cross-Sectional Countrywide Study.
Hammoudi Halat D; Moubareck CA; Sarkis DK
Microb Drug Resist; 2017 Sep; 23(6):733-743. PubMed ID: 28080212
[TBL] [Abstract][Full Text] [Related]
36. Novel multiplex PCRs for detection of the most prevalent carbapenemase genes in Gram-negative bacteria within Germany.
Cerezales M; Biniossek L; Gerson S; Xanthopoulou K; Wille J; Wohlfarth E; Kaase M; Seifert H; Higgins PG
J Med Microbiol; 2021 Mar; 70(3):. PubMed ID: 33448924
[No Abstract] [Full Text] [Related]
37. SURVEILLANCE of CARBAPENEM NON-SUSCEPTIBLE GRAM NEGATIVE STRAINS and CHARACTERIZATION of CARBAPENEMASES of CLASSES A, B and D in a LEBANESE HOSPITAL.
Hammoudi D; Moubareck CA; Kanso A; Nordmann P; Sarkis DK
J Med Liban; 2015; 63(2):66-73. PubMed ID: 26164974
[TBL] [Abstract][Full Text] [Related]
38. Carbapenem-resistant Gram-negative bacteria associated with catheter-related bloodstream infections in three intensive care units in Egypt.
Abdulall AK; Tawfick MM; El Manakhly AR; El Kholy A
Eur J Clin Microbiol Infect Dis; 2018 Sep; 37(9):1647-1652. PubMed ID: 29936619
[TBL] [Abstract][Full Text] [Related]
39. Characterization of carbapenem-resistant Pseudomonas aeruginosa clinical isolates, carrying multiple genes coding for this antibiotic resistance.
Rizek C; Fu L; Dos Santos LC; Leite G; Ramos J; Rossi F; Guimaraes T; Levin AS; Costa SF
Ann Clin Microbiol Antimicrob; 2014 Sep; 13():43. PubMed ID: 25179208
[TBL] [Abstract][Full Text] [Related]
40. Impact of bloodstream infections caused by carbapenem-resistant Gram-negative pathogens on ICU costs, mortality and length of stay.
Kousouli E; Zarkotou O; Polimeri K; Themeli-Digalaki K; Pournaras S
Infect Prev Pract; 2019 Jun; 1(2):100020. PubMed ID: 34368681
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
